16.02.2011
- Sanofi-Aventis SA has agreed in principle to acquire Genzyme Corp for $19.2 billion in cash plus future payments based on the performance of an experimental Genzyme drug, according...
21.12.2010
- Novozymes, the world's top industrial enzymes maker, is buying U.S. based EMD/Merck Crop BioScience for $275 million from Merck KGaA , boosting its presence in the fast-growing...
14.12.2010
- The potato starch manufacturer Avebe and the plant biotechnology company BASF Plant Science announced a research and development alliance in plant biotechnology. The companies are...
13.12.2010
- Spain announced a €82.84 billion plan to stimulate growth in its industrial sector over the next five years on Friday, part of its previously announced Sustainable Economy Strategy...
06.12.2010
- Roche Holding Chief Executive Severin Schwan believes the survivors in the pharmaceuticals sector will be large generic drugmakers, and companies who make innovative new products...
02.12.2010
- U.S. pharmaceutical company Merck & Co. is set to buy SmartCells Inc, a privately held biotechnology firm in the early stages of developing a new diabetes drug, the Wall Street...
28.10.2010
- Danish-listed biotech Genmab is vulnerable to a takeover due to its current low share price, and the company needs more time to develop its full potential, its chief executive told...
24.08.2010
- U.S. biotechnology firm Genzyme and its French suitor Sanofi-Aventis are at odds over the threshold price at which Sanofi could begin the due diligence on Genzyme's books, the Wall...